Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
ABMC American Bio Medica		$0.00	$0.00 ▼ $0.00	$5K	-1.86	18,714 shs	N/A
MSLP MusclePharm		$0.00	$0.00 ▼ $0.00	$7K	-0.07	26,442 shs	N/A
STAB Statera Biopharma	$0.00	$0.00	$0.00 ▼ $0.13	$5K	0.1	9,158 shs	415 shs
TLOG TetraLogic Pharmaceuticals		$0.00	$0.00 ▼ $0.00	$2K	N/A	N/A	N/A

7 Stocks to Buy And Hold Forever

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
ABMC American Bio Medica	0.00%	0.00%	0.00%	0.00%	0.00%
MSLP MusclePharm	0.00%	0.00%	0.00%	0.00%	-83.33%
STAB Statera Biopharma	0.00%	0.00%	0.00%	0.00%	-83.33%
TLOG TetraLogic Pharmaceuticals	0.00%	0.00%	0.00%	0.00%	0.00%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	Dividend Strength	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
ABMC American Bio Medica	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
MSLP MusclePharm	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
STAB Statera Biopharma	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
TLOG TetraLogic Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Compare Analyst Forecasts

Company	Consensus Rating	Consensus Price Target	% Upside from Current Price
ABMC American Bio Medica	N/A	N/A	N/A
MSLP MusclePharm	N/A	N/A	N/A
STAB Statera Biopharma	N/A	N/A	N/A
TLOG TetraLogic Pharmaceuticals	N/A	N/A	N/A

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
ABMC American Bio Medica	$910K	0.00	N/A	N/A	N/A	NaN
MSLP MusclePharm	$50.04M	0.00	N/A	N/A	($0.94) per share	0.00
STAB Statera Biopharma	N/A	N/A	N/A	N/A	N/A	N/A
TLOG TetraLogic Pharmaceuticals	N/A	N/A	N/A	N/A	N/A	N/A

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
ABMC American Bio Medica	-$1.41M	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A
MSLP MusclePharm	-$12.87M	-$0.58	N/A	N/A	N/A	-38.51%	N/A	-169.56%	N/A
STAB Statera Biopharma	N/A	N/A	0.00	∞	N/A	N/A	N/A	N/A	N/A
TLOG TetraLogic Pharmaceuticals	N/A	N/A	0.00	N/A	N/A	N/A	N/A	N/A	N/A

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
ABMC American Bio Medica	N/A	N/A	N/A	N/A	N/A
MSLP MusclePharm	N/A	N/A	N/A	N/A	N/A
STAB Statera Biopharma	N/A	N/A	N/A	N/A	N/A
TLOG TetraLogic Pharmaceuticals	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
ABMC American Bio Medica	N/A	N/A	N/A
MSLP MusclePharm	N/A	0.25	0.23
STAB Statera Biopharma	N/A	N/A	N/A
TLOG TetraLogic Pharmaceuticals	N/A	N/A	N/A

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
ABMC American Bio Medica	N/A
MSLP MusclePharm	15.49%
STAB Statera Biopharma	N/A
TLOG TetraLogic Pharmaceuticals	0.02%

Insider Ownership

Company	Insider Ownership
ABMC American Bio Medica	3.10%
MSLP MusclePharm	60.70%
STAB Statera Biopharma	5.50%
TLOG TetraLogic Pharmaceuticals	15.40%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
ABMC American Bio Medica	30	48.10 million	46.61 million	Not Optionable
MSLP MusclePharm	20	33.39 million	13.12 million	Not Optionable
STAB Statera Biopharma	20	53.30 million	N/A	Not Optionable
TLOG TetraLogic Pharmaceuticals	29	24.32 million	20.57 million	Not Optionable

TLOG, MSLP, ABMC, and STAB Headlines

Recent News About These Companies

TetraLogic Pharmaceuticals Corp (TLOG)

May 5, 2025 | nasdaq.com

TetraLogic Pharmaceuticals Corporation (TLOG)

August 29, 2024 | sg.finance.yahoo.com

Inovio Pharmaceuticals, Inc. Common Stock (INO)

January 28, 2024 | nasdaq.com

TetraLogic Pharma (TLOG) Earnings Dates & Reports

August 4, 2023 | investing.com

Sotac Pharmaceuticals SME IPO: Check Day 1 subscription status and GMP signal

April 1, 2023 | livemint.com

Media Sentiment Over Time

TLOG, MSLP, ABMC, and STAB Company Descriptions

American Bio Medica OTCMKTS:ABMC

American Bio Medica Corporation engages in manufacture and sale of lateral flow immunoassay tests primarily for the immediate detection of drugs in urine and oral fluids. Its drugs detection products in urine include Rapid Drug Screen, a rapid drug test, which detects the presence or absence of 2 to 10 drugs; RDS InCup, a drug-testing cup that detects the presence or absence of 1 to 12 drugs; Rapid TOX, a drug test in a cassette platform, which detects the presence or absence of 1 to 10 drugs; and Rapid TOX Cup II, a drug testing cup that detects the presence or absence of 1 to 16 drugs. The company also offers a test for the detection of respiratory syncytial virus; OralStat, a drug test for the detection of drugs in oral fluids, as well as private labeled versions of OralStat. In addition, the company distributes other products for the detection of substances of abuse, as well as products to detect certain infectious diseases. Further, it provides strip contract manufacturing, assembly, and packaging services to unaffiliated diagnostic companies. The company serves rehabilitation/drug treatment, pain management, other clinical, government, and employment/workplace markets. It operates in the United States, North America, Europe, the Asia Pacific, and South America. The company was formerly known as American Micro Media, Inc. and changed its name to American Bio Medica Corporation in September 1992. American Bio Medica Corporation was incorporated in 1986 and is based in Kinderhook, New York.

MusclePharm OTCMKTS:MSLP

MusclePharm Corporation develops, manufactures, markets, and distributes sports nutrition products and nutritional supplements in the United States and internationally. The company offers a range of performance powders, capsules, tablets, gels, and on-the-go ready to eat snacks. Its MusclePharm brand product portfolio includes combat protein powder and combat crunch protein bars; and essential supplements, such as a BCAA, creatine, glutamine, carnitine, CLA, fish oil, multi-vitamin, and other products. The company also provides FitMiss branded sports nutrition products, which are formulated primarily for the female body to support women in the areas of weight management, lean muscle mass, body composition, and general health and wellness; and functional energy beverages under the Combat Energy and FitMiss Energy brands. It sells its products to various athletes and fitness enthusiasts. The company was incorporated in 2006 and is based in Las Vegas, Nevada.

Statera Biopharma NASDAQ:STAB

$0.0001 0.00 (0.00%)

As of 05/30/2025 11:51 AM Eastern

Statera BioPharma, Inc., a clinical-stage biopharmaceutical company, develops novel immunotherapies targeting autoimmune, neutropenia/anemia, emerging viruses, and cancers based on a proprietary platform designed to rebalance the body's immune system and restore homeostasis. The company is developing therapies designed to directly elicit within patients a response of antigen-specific killer T-cells and antibodies, thereby activating essential immune defenses against autoimmune, inflammatory, infectious diseases, and cancers. It has clinical programs for Crohn's disease (STAT-201), hematology (Entolimod), pancreatic cancer (STAT-401), and COVID-19 (STAT-205), as well as fibromyalgia and multiple sclerosis. The company was formerly known as Cytocom, Inc. and changed its name to Statera Biopharma, Inc. in September 2021. Statera Biopharma, Inc. is based in Fort Collins, Colorado.

TetraLogic Pharmaceuticals OTCMKTS:TLOG

TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cutaneous T-cell lymphoma. TetraLogic Pharmaceuticals Corporation has research collaboration with Walter and Eliza Hall Institute of Medical Research to examine SMAC-mimetics, including birinapant in the treatment of infectious disease. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time